Shares in nearly all major drugmakers lost value Monday, a market reaction that suggest the industry is taking seriously the prospect of new action on drug pricing from President Donald Trump.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,